Acceptability and use of a dapivirine vaginal ring in a phase III trial
Elizabeth Montgomery(RTI International), Jared M. Baeten(University of Washington), Millicent Atujuna(Desmond Tutu HIV Foundation), Miria Chitukuta(University of Zimbabwe-University of California San Francisco), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Krishnaveni Reddy(Perinatal HIV Research Unit), Ashley Mayo(Family Health International 360), Kubashni Woeber(South African Medical Research Council), Thesla Palanee‐Phillips(University of the Witwatersrand), Ariane van der Straten(University of California, San Francisco), Juliane Etima(MUJHU Research Collaboration), Teopista Nakyanzi(MUJHU Research Collaboration), Cynthia I. Grossman(National Institute of Mental Health), Nicole Laborde, Lydia Soto‐Torres(National Institutes of Health), Ariana W. K. Katz(RTI International)
Cited by 137
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|623
Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2
|New England Journal of Medicine|2010|532